Practice Matters Online First (2026)

Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy

A pharmacist-led clinical support program was implemented across a large health-care network in order to standardize and improve the care of patients with polycythemia vera. Pharmacists provided clinical reviews, pharmacotherapy recommendations, and financial access support in order to improve hematocrit control and symptom assessment.

Umesh Yogarajah Thuy Tran Erin Cichonski Benson Meek John Bentz RPh Nicole Cowgill Allison Karabinos Justin R. Arnall

July 1, 2026 Online First (2026) https://doi.org/10.6004/jadpro.2026.17.7.22

Share

Top Institutions in Hematology

Ranking is based on citation frequency across our internal corpus of peer-reviewed articles.

#1

Cancer Treatment Centers of America

Zion, Illinois
Strong affiliation with key personnel in hematology and a focus on collaborative care models.
Key Differentiators
- Hematology
#2

Specialty Pharmacy Service (SPS)

Not specified, Not specified
Partnered with leukemia care teams to enhance clinical support for Polycythemia Vera management.
Key Differentiators
- Pharmacy
#3

University of Oklahoma Health Sciences

Oklahoma City, Oklahoma
Involved in significant research and education in hematologic malignancies.
Key Differentiators
- Hematology
#4

Fox Chase Cancer Center

Philadelphia, Pennsylvania
Active in research and education related to complex surgical oncology.
Key Differentiators
- Oncology
#5

Mayo Clinic

Rochester, Minnesota
Recognized as a leading academic center involved in multiple studies on hematologic conditions.
Key Differentiators
- Hematology

AI in Oncology Opportunity and Accountability

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, TCTCN, FAAN, FAPO

May 13, 2026

The Impact of Physical Activity Levels on Sexual Function in Breast Cancer Survivors An Integrative Review

Mary Sou, MSN, APRN, FNP-C, Ashley Martinez, DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, NPD-BC, Joyce Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP, FAAN Et al.

May 13, 2026

Addressing Tamoxifen-Associated Weight Gain Lifestyle and Pharmacotherapy Options

Latonya Fore-Williams, DNP, APRN, NP-C, CSOWM, CBN, CCM, Michele Distler, DNP, RN, CNE

May 13, 2026

Table of Contents Archive

Umesh Yogarajah

Pharmacist

Affiliations: Levine Cancer Institute

Specialties: Hematology

Bio: Umesh Yogarajah, PharmD, BCOP, serves as a pharmacist at Levine Cancer Institute, a leading regional hematologic malignancy center. He specializes in hematology oncology pharmacy with a focus on the management of myeloproliferative neoplasms such as polycythemia vera. Dr. Yogarajah played a key role in implementing a pharmacist-led clinical support program designed to optimize polycythemia vera care through collaborative efforts with leukemia oncologists and an integrated specialty pharmacy. His work involves conducting clinical reviews, providing pharmacotherapy recommendations, supporting financial access, and coordinating patient care to improve hematocrit control and symptom management. This initiative highlights the potential of advanced practitioners in improving treatment outcomes and quality of life for patients with chronic hematologic disorders.

Thuy Tran

Pharmacist Specialist

Affiliations: Levine Cancer Institute

Specialties: Oncology

Bio: Thuy Tran, PharmD, BCOP, CSP, serves as a pharmacist specialist at Levine Cancer Institute, a leading regional hematologic malignancy center. She is instrumental in a pharmacist-led clinical support program designed to optimize management of polycythemia vera (PV) through collaboration with leukemia oncologists and an integrated specialty pharmacy service. Her work focuses on improving hematologic control and symptom assessment for patients with PV by providing clinical reviews, pharmacotherapy recommendations, and financial access support. Dr. Tran’s expertise lies in hematologic malignancies with a specialty in oncology pharmacy practice. Her contributions have directly influenced enhanced disease management and quality of life for patients with chronic myeloproliferative neoplasms. She actively facilitates coordination of care within multidisciplinary teams, employing advanced pharmacy practice to standardize treatment protocols across healthcare networks.

Erin Cichonski

Pharmacist

Affiliations: Levine Cancer Institute

Specialties: Hematology

Bio: Erin Cichonski, PharmD, is a pharmacist at Levine Cancer Institute in Charlotte, NC. She plays a pivotal role in a pharmacist-led clinical support program designed to optimize management of polycythemia vera (PV) by standardizing care and improving patient outcomes. Her work includes conducting clinical reviews, providing pharmacotherapy recommendations, and supporting patients with financial access and medication education. Dr. Cichonski's contributions focus particularly on improving hematocrit control and symptom assessment scores in collaboration with integrated specialty pharmacy services. Her expertise lies in hematology pharmacy, where she supports multidisciplinary teams to enhance disease management for hematologic malignancies. She has contributed to advancing clinical workflows that enable sustained provider engagement and improved quality of life for patients with PV through comprehensive pharmacy-led initiatives.

Benson Meek

Affiliations: Levine Cancer Institute

Bio: Benson Meek, PharmD, is a pharmacist who contributed to the implementation of a pharmacist-led clinical support program at Levine Cancer Institute. This program focuses on optimizing the management of polycythemia vera by providing clinical reviews, pharmacotherapy recommendations, financial access support, and medication education. The initiative aims to standardize care, improve hematocrit control, and enhance symptom assessment for patients with this chronic myeloproliferative neoplasm. Dr. Meek's work highlights the critical role of specialty pharmacists in collaborative care models for hematologic malignancies, demonstrating how integrated pharmacy services can improve disease control and patients' quality of life.

John Bentz

Bio: John Bentz is a contributing author involved in interdisciplinary research spanning hematologic malignancies, oncology, and pathology. His recent work includes collaborative efforts to optimize polycythemia vera management through pharmacist-led clinical support programs and integrated specialty pharmacy models. Bentz's research contributions extend to various clinical and pathological conditions, including gynecologic oncology, dermatopathology, and cardiovascular imaging, demonstrating a broad scope of interest in medical science and patient care.

Nicole Cowgill

Pharmacist

Affiliations: Levine Cancer Institute

Specialties: Hematology

Bio: Nicole Cowgill, PharmD, CSP, BCOP, DPLA, is a pharmacist at Levine Cancer Institute, where she focuses on optimizing care for patients with hematologic malignancies. She played a key role in implementing a pharmacist-led clinical support program aimed at improving management of polycythemia vera by providing clinical reviews, pharmacotherapy recommendations, and financial access support. Her work highlights the important role of specialty pharmacy integration in enhancing therapeutic outcomes and quality of life for patients with myeloproliferative neoplasms. Dr. Cowgill's contributions emphasize collaborative care models and the optimization of symptom assessment and disease control through multidisciplinary coordination.

Allison Karabinos

Bio: Allison Karabinos, PharmD, is a pharmacist recognized for her contributions to the management of polycythemia vera through integrated specialty pharmacy services. She played a key role in implementing a pharmacist-led clinical support program aimed at standardizing care, improving hematocrit control, and enhancing symptom assessment for patients with this chronic myeloproliferative neoplasm. Her work focuses on clinical reviews, pharmacotherapy recommendations, and facilitating patient access to therapies in collaboration with oncology specialists.

Justin R. Arnall

Specialties: Oncology

Bio: Justin R. Arnall, PharmD, BCOP, FCCP, is an oncology pharmacist and medical author. His work in JADPRO addresses pharmacologic management of congenital thrombotic thrombocytopenic purpura, including recombinant ADAMTS13 enzyme replacement therapy. His published work also includes review of caplacizumab, an anti–von Willebrand factor antibody used in thrombotic thrombocytopenic purpura, reflecting a focus on hematology-related pharmacotherapy.

Contributions:

https://jadpro.com/issues/volume-17-number-3-mayjun-2026/advanced-practitioner-professional-development-through-publication/

https://jadpro.com/online-first/2026/recombinant-adamts13-an-enzyme-replacement-therapy-for-the-management-of-cttp/